High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
-
Boris T. Ivandic
,
Eberhard Spanuth
Abstract
Background: Cardiac troponin T is an established prognostic marker in patients with acute coronary syndromes, but not in stable coronary artery disease (CAD) like N-terminal pro-B-type natriuretic peptide (NT-proBNP). We examined the additive prognostic value of a high-sensitivity troponin T (hsTnT) assay to predict adverse clinical outcomes in stable CAD.
Methods: A retrospective nested case-control analysis of 256 patients with stable CAD who participated in the LURIC study: 128 cases who died from cardiovascular causes during a median follow-up of 7.5 years and 128 survivors (controls) matched for age and gender, were included. hsTnT and NT-proBNP were determined in baseline samples using immunoassays (Roche Diagnostics, Germany).
Results: Sixty-two percent of the 256 subjects exhibited concentrations of hsTnT≥14 ng/L, the manufacturer recommended cut-off to diagnose myocardial infarction in patients with acute chest pain. hsTnT, NT-proBNP, diabetes mellitus and fasting glucose were associated with cardiovascular mortality in univariate analysis. Logistic regression identified hsTnT and NT-proBNP as independent risk markers. Receiver operator characterisitc (ROC) curves analysis identified optimal cut-offs at 15 ng/L and 352 μg/L for hsTnT (AUC 0.728, p<0.05) and NT-proBNP (AUC 0.751, p=0.07), respectively. Patients with one or two positive markers exhibited 5-year cardiovascular mortalities of 40% and 60%, respectively, compared to 10% in patients with negative markers. The addition of hsTnT to NT-proBNP significantly increased c-statistics of proportional hazards calculated from survival times as well as net reclassification indexes.
Conclusions: Many patients with stable CAD exhibited increased concentrations of hsTnT. The combined determination of NT-proBNP and hsTnT was superior for risk stratification compared to determining either marker alone.
©2011 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Editors’ and Publisher’s Note
- CCLM Award for The Most Cited Paper Recently Published
- Reviews
- Some views on proteomics in diabetes
- Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics
- Minireviews
- Low-density lipoprotein receptor-related protein 1: new functions for an old molecule
- Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
- Opinion Paper
- Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization
- General Clinical Chemistry and Laboratory Medicine
- Use of a fully automated immunoassay for celiac disease screening in a pediatric population
- Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure
- Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
- Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia
- The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study
- Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
- Perchlorate (Irenat®) may falsely lower measured ionised calcium
- Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
- A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
- Reference Values and Biological Variations
- Reference change values for monitoring dehydration
- Cancer Diagnostics
- Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis
- Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study
- Cardiovascular Diseases
- High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
- Letters to the Editor
- Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes
- Trueness assessment of Korean nation-wide glucose proficiency testing
- Genetic polymorphism of cytochrome P450 1A1 in a northern Italian population: high frequency of the CYP1A1*2C allele
- Prestaining of PCR products with SYBR Green for agarose gel electrophoresis: advantages and limitations
- A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells
- Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial
- Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method
- Cross-reactivity of insulin analogs with the Diasorin Liaison Insulin assay
- Improved turnaround time for neonatal hematology profile tests (complete blood count) using a new microcollection tube
- Erratum
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Articles in the same Issue
- Editors’ and Publisher’s Note
- CCLM Award for The Most Cited Paper Recently Published
- Reviews
- Some views on proteomics in diabetes
- Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics
- Minireviews
- Low-density lipoprotein receptor-related protein 1: new functions for an old molecule
- Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
- Opinion Paper
- Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization
- General Clinical Chemistry and Laboratory Medicine
- Use of a fully automated immunoassay for celiac disease screening in a pediatric population
- Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure
- Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
- Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia
- The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study
- Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
- Perchlorate (Irenat®) may falsely lower measured ionised calcium
- Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
- A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
- Reference Values and Biological Variations
- Reference change values for monitoring dehydration
- Cancer Diagnostics
- Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis
- Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study
- Cardiovascular Diseases
- High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
- Letters to the Editor
- Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes
- Trueness assessment of Korean nation-wide glucose proficiency testing
- Genetic polymorphism of cytochrome P450 1A1 in a northern Italian population: high frequency of the CYP1A1*2C allele
- Prestaining of PCR products with SYBR Green for agarose gel electrophoresis: advantages and limitations
- A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells
- Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial
- Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method
- Cross-reactivity of insulin analogs with the Diasorin Liaison Insulin assay
- Improved turnaround time for neonatal hematology profile tests (complete blood count) using a new microcollection tube
- Erratum
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
